Skip to content
Aperlena
Free alerts

România - Imunosupresoare - ACORD CADRU FURNIZARE MEDICAMENTEMEDICAMENTE: eculizumab si ravulizumab_P6.30: HEMOGLOBINURIE PAROXISTICA NOCTURNA (HPN)

Awarded Contract award

Key facts

Winner
FARMEXIM S.A.; ALLIANCE HEALTHCARE ROMÂNIA SRL; DR.MAX
Awarded value
€157,466
Buyer
SPITALUL CLINIC JUDETEAN DE URGENTA SF.SPIRIDON IASI
Where
Romania Nord-Est
Procedure
Open procedure Anyone may submit a bid, in one step, with no pre-selection. Full entry Above the EU threshold A contract large enough that EU-wide rules apply and it must be published on TED. Full entry
CPV code The EU's common vocabulary for what is being bought: an eight-digit code every notice carries. Full entry
33652300 Immunosuppressive agents
Original language
Romanian
Source
via TED - Tenders Electronic Daily (Publications Office of the EU), verified 1 month ago
Notice number
37381-2026
Watch this tender

Bidding is closed. An award or a correction on this notice: an email when the register sees it. Log in

  1. Published
  2. Awarded pending

Description

Medicamente - Program Nationale de Sanatate_HPN_, eculizumab si ravulizumab, conform centralizatorului atasat si conform specificatiilor din caietul de sarcini care face parte integranta din documentatia de atribuire si constituie ansamblul cerintelor pe baza carora se elaboreaza de catre fiecare ofertant propunerea tehnica. Numar zile pana la care se pot solicita clarificari inainte de data limita de depunere a ofertelor/candidaturilor: 19 zile. Autoritatea contractanta va raspunde in mod clar si complet tuturor solicitarilor de clarificari/informatiilor suplimentare in a 11-a zi inainte de data limita de depunere a ofertelor” pentru respectarea prevederilor art.160-161 din Legea nr.98/2016, Art.8 din HG 419/2018 ECULIZUMABUM 300 mg - 1 flac. de 30 ml contine eculizumab 300 mg (10 mg/ml, 300 mg); concentrat de solutie perfuzabila; cant min ctr. subsecvent = 36 cant max ctr. subsecvent = 108 cant min acord cadru = 432 cant maxc acord cadru = 1296; RAVULIZUMABUM 300 mg - 1 flac. de 3 ml contine ravulizumab 300 mg (100 mg/ml); concentrat de solutie perfuzabila; cant min ctr. subsecvent = 5 cant max ctr. subsecvent = 15 cant min acord cadru = 54 cant maxc acord cadru = 162; RAVULIZUMABUM 1100 mg - 1 flac. de 11 ml contine ravulizumab 1100 mg (100 mg/ml); concentrat de solutie perfuzabila; cant min ctr. subsecvent = 9 cant max ctr. subsecvent = 27 cant min acord cadru = 108 cant maxc acord cadru = 324

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago

View the official notice

More from this buyer

Full buyer profile

6 open tenders right now

Recent awards

Change history

Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.

  1. Read before bidding
    • Scope and criteria: The description was expanded. Re-read it before you bid.
    • Award value: Raised to €157,466 (+0%)

Follow this tender and we email you the moment it changes. Create account

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€11,312,785
9,906 open across Europe right now
Buyer track record on Aperlena
107 notices tracked · 78 awarded
€22,664,107 in awarded contracts

Never miss a tender like this

348 new notices in Medical equipment & pharmaceuticals in Romania in the last 7 days. Get an email when new ones appear. Free.

Set up my alert
Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Start from a question

Browse by sector

Index

Close
Log in

Language